Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Rock Springs Capital Management LP Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/15/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 0% stake in Sierra Oncology, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 0% stake in PhaseBio Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 4.9% stake in Mirum Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 4.2% stake in Compass Therapeutics, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 7.8% stake in Tempest Therapeutics, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 6.9% stake in Spruce Biosciences, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 5.3% stake in MEREO BIOPHARMA GROUP PLC
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 7.6% stake in Inozyme Pharma, Inc.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 7.3% stake in Immunocore Holdings plc
02/14/2023 SC 13G Rock Springs Capital Management LP reports a 5.6% stake in AEGLEA BIOTHERAPEUTICS, INC.
02/14/2023 SC 13G Rock Springs Capital Management LP reports a 5.4% stake in AGIOS PHARMACEUTICALS, INC.
02/14/2023 SC 13G/A Rock Springs Capital Management LP reports a 5.9% stake in Aclaris Therapeutics, Inc.
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
04/25/2022 SC 13G Rock Springs Capital Management LP reports a 6.1% stake in Inozyme Pharma, Inc.
02/15/2022 SC 13G Rock Springs Capital Management LP reports a 5.1% stake in MEREO BIOPHARMA GROUP PLC
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Rock Springs Capital Management LP reports a 6.9% stake in Spruce Biosciences, Inc.
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Rock Springs Capital Management LP reports a 5% stake in Mirum Pharmaceuticals, Inc.
02/14/2022 SC 13G/A Rock Springs Capital Management LP reports a 5.6% stake in Immunocore Holdings plc
02/14/2022 SC 13G/A Rock Springs Capital Management LP reports a 5.4% stake in Compass Therapeutics, Inc.
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
01/10/2022 3 Rock Springs Capital Management LP (10% Owner) has filed a Form 3 on Tempest Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy